In summary, this preliminary study on leveraging the immune system response to a combination treatment of LIFE Biomaterial_anti-CD40 and FLASH-RT showed the potential recruitment of the T-lymphocytes in the tumor microenvironment. This evidence concerns the gene CD40 and neoplasm.